PGEN
Precigen Inc
Price:  
1.70 
USD
Volume:  
1,742,436.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PGEN Relative Valuation

-808.6%
Upside

As of 2025-07-09, the Relative Valuation of Precigen Inc (PGEN) is (12.05) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.70 USD, the upside of Precigen Inc based on Relative Valuation is -808.6%.

The range of the Relative Valuation is (9.63) - (12.87) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 18.1x - 26.4x 25.7x
Forward P/E multiples 16.1x - 24.3x 19.7x
Fair Price (9.63) - (12.87) (12.05)
Upside -666.3% - -857.3% -808.6%
1.70 USD
Stock Price
(12.05) USD
Fair Price

PGEN Relative Valuation - Historical P/E Data

Date P/E
2025-07-07 -3.00
2025-07-03 -3.05
2025-07-02 -3.03
2025-07-01 -2.73
2025-06-30 -2.68
2025-06-27 -2.68
2025-06-26 -2.69
2025-06-25 -2.68
2025-06-24 -2.83
2025-06-23 -2.79
2025-06-20 -2.73
2025-06-18 -2.81
2025-06-17 -2.68
2025-06-16 -2.90
2025-06-13 -2.86
2025-06-12 -2.86
2025-06-11 -2.83
2025-06-10 -2.90
2025-06-09 -2.83
2025-06-06 -2.83
2025-06-05 -2.51
2025-06-04 -2.51
2025-06-03 -2.56
2025-06-02 -2.51
2025-05-30 -2.49
2025-05-29 -2.62
2025-05-28 -2.58
2025-05-27 -2.66
2025-05-23 -2.58
2025-05-22 -2.62
2025-05-21 -2.49
2025-05-20 -2.66
2025-05-19 -2.56
2025-05-16 -2.73
2025-05-15 -2.47
2025-05-14 -2.41
2025-05-13 -2.54
2025-05-12 -2.58
2025-05-09 -2.51
2025-05-08 -2.54
2025-05-07 -2.54
2025-05-06 -2.63
2025-05-05 -2.86
2025-05-02 -2.96
2025-05-01 -2.92
2025-04-30 -2.94
2025-04-29 -2.90
2025-04-28 -2.92
2025-04-25 -2.83
2025-04-24 -3.00